%=======================================================================================%
\chapter*{List of Abbreviations}
\label{chap:abbrev}

\begin{center}
\begin{bfseries}
\newcommand\nomenclature[2]{#1 & #2 \\}
\begin{longtable}{@{}p{3cm}@{}p{\dimexpr\textwidth-1cm\relax}@{}}
\nomenclature{${\small AMBER}$}    {Assisted Model Building with Energy Refinement}
\nomenclature{${\small ABC}$}   {ATP-Binding Cassette transporter}
\nomenclature{${\small ALI}$}   {Air-Liquid Interface}
\nomenclature{${\small ATP}$}      {Adenosine Tri-Phosphate}
\nomenclature{${\small BAR}$}      {Bennett-Acceptance-Ratio}
\nomenclature{${\small CF}$}        {Cystic Fibrosis}
\nomenclature{${\small CFTR}$}      {Cystic Fibrosis Transmembrane Conductance Regulator, also designated ABCC7. hCFTR is human CFTR and zCFTR is zebrafish CFTR}
\nomenclature{${\small CHARMM}$}   {Chemistry at Harvard Macromolecular Mechanics}
\nomenclature{${\small CMAP}$}     {energy grid correction map}
\nomenclature{${\small CHO}$}      {Chinese Hamster Ovary}
\nomenclature{${\small COM}$}      {Centre of Mass}
\nomenclature{${\small Cryo-EM}$}  {Cryogenic Electron Microscopy}
\nomenclature{${\small CV}$}       {Collective Variable}
\nomenclature{${\small DMSO}$}     {Dimethyl Sulfoxide}
\nomenclature{${\small DNA}$}      {Deoxyribose Nucleic Acid}
\nomenclature{${\small ETI}$}      {elexacaftor/tezacaftor/ivacaftor + ivacaftor, Trikafta, triple combination therapy}
\nomenclature{${\small FEP}$}      {Free-Energy Perturbation}
\nomenclature{${\small FEV1\%}$}   {Forced Expiratory Volume in 1 second}
\nomenclature{${\small FES}$}      {Free Energy Surface}
\nomenclature{${\small FIS}$}      {Forskolin-Induced Swelling}
\nomenclature{${\small Fsk}$}      {Forskolin}
\nomenclature{${\small gA}$}       {Gramicidin A Ion Channel}
\nomenclature{${\small GROMACS}$}  {GROningen MAchine for Chemical Simulations - MD program}
\nomenclature{${\small GROMOS}$}   {GROningen MOlecular Simulation - MD program}
\nomenclature{${\small hNEC}$}     {human Nassal Epithelial Cells}
\nomenclature{${\small iPCR}$}     {inverse Polymerase Chain Reaction}
\nomenclature{${\small iPSCs}$}    {induced Pluripotent Stem Cells}
\nomenclature{${\small Isc}$}      {Short Circuit current}
\nomenclature{${\small LJ}$}       {Lenard-Jones}
\nomenclature{${\small MBAR}$}     {Multistate Bennett-Acceptance-Ratio}
\nomenclature{${\small MD}$}       {Molecular Dynamics}
\nomenclature{${\small MM}$}       {Molecular Mechanics}
\nomenclature{${\small MetaD}$}    {Metadynamics}
\nomenclature{${\small WT-MetaD}$} {Well-Tempered Metadynamics}
\nomenclature{${\small NAMD}$}     {Nanoscale Molecular Dynamics - MD Program}
\nomenclature{${\small NBD}$}      {Nucleotide Binding Domain}
\nomenclature{${\small NPT}$}      {Constant Number of particles, Pressure and Temperature. Isothermal-Isobaric Ensemble}
\nomenclature{${\small NVE}$}      {Constant Number of particles, Volume and Energy. Microcanonical Ensemble}
\nomenclature{${\small NVT}$}      {Constant Number of particles, Volume and Temperature. Canonical Ensemble}
\nomenclature{${\small OpenMM}$}   {Open Molecular Mechanics - MD Program}
\nomenclature{${\small OPES}$}     {On the fly Probability Enhanced Sampling}
\nomenclature{${\small OPLS}$}     {Optimised Potentials for Liquid Simulations}
\nomenclature{${\small PBC}$}      {Periodic Boundary Condition}
\nomenclature{${\small PC}$}       {Principal Component}
\nomenclature{${\small PCA}$}      {Principal Component Analysis}
\nomenclature{${\small PDB}$}      {Protein Data Bank}
\nomenclature{${\small PGP}$}      {P-Glyco Protein, also designated ABCB1}
\nomenclature{${\small PI}$}       {Pancreatic Insufficient}
\nomenclature{${\small PKA}$}      {Protein Kinase A}
\nomenclature{${\small PMF}$}      {Potential of Mean Force}
\nomenclature{${\small PME}$}      {Particle Mesh Ewald - Long-range Electrostatics Method}
\nomenclature{${\small POPC}$}     {1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. The most common lipid used in molecular dynamics simulations of eukaryotic cells.}
\nomenclature{${\small RAVE}$}     {Reweighted Autoencoded Variational bayes for Enhanced sampling}
\nomenclature{${\small RC}$}       {Reaction Coordinate}
\nomenclature{${\small RNA}$}      {Ribose-neucleic acid}
\nomenclature{${\small TICA}$}     {Time-lagged Independent Component Analysis}
\nomenclature{${\small TM}$}       {TransMembrane}
\nomenclature{${\small TMD}$}      {Transmembrane Domain}
\nomenclature{${\small TMH}$}      {Transmembrane helix}
\nomenclature{${\small US}$}       {Umbrella Sampling}
\nomenclature{${\small VAC}$}      {Variational Approach to Conformational dynamics}
\nomenclature{${\small VMD}$}      {Visual Molecular Dynamics - MD Visualisation Program}
\nomenclature{${\small VUS}$}      {Variants of Unknown Significance}
\nomenclature{${\small WHAM}$}     {Weighted Histogram Analysis Method}
\end{longtable}
\end{bfseries}
\end{center}
